Duloxetine

Product NDC
65862-452
11-digit product format
658620452
Labeler code
65862
Product ID
65862-452_f64ca39e-f7fc-45e5-a2bf-23b39ada6998
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Duloxetine Hydrochloride
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA090778
Marketing category
ANDA
Marketing start
2013-12-11
Marketing end
0000-00-00
Substance
DULOXETINE HYDROCHLORIDE
Active strength
30 mg/1
Pharmacologic classes
Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
65862-452-306586204523030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-452-30) 2013-12-110000-00-00NoNoCurrent
65862-452-59658620452595000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-452-59) 2013-12-110000-00-00NoNoCurrent
65862-452-786586204527810 BLISTER PACK in 1 CARTON (65862-452-78) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (65862-452-10) 10 blister pack2013-12-110000-00-00NoNoCurrent
65862-452-906586204529090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-452-90) 2013-12-110000-00-00NoNoCurrent
65862-452-99658620452991000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-452-99) 2013-12-110000-00-00NoNoCurrent